Residency · Residency · Child Adolescent Psychiatry
Telepsychiatry with Children and Adolescents
Introduction
Telepsychiatry refers to the delivery of psychiatric services via videoconferencing or other telecommunications technology. The COVID-19 pandemic dramatically accelerated its adoption in child and adolescent psychiatry, transforming it from a niche modality into a mainstream component of care delivery. Telepsychiatry has demonstrated particular value in addressing the severe shortage of child and adolescent psychiatrists, especially in rural and underserved areas.
Historical Context and Current Landscape
The Massachusetts Child Psychiatry Access Program (MCPAP) was an early model for teleconsultation that demonstrated the feasibility and impact of remote psychiatric support for primary care providers. Prior to the pandemic, fewer than 15% of child psychiatrists used telehealth regularly; post-pandemic, rates exceed 70%. The AACAP endorses telepsychiatry as effective and appropriate for a wide range of clinical services. Federal and state policy changes during the pandemic, including Ryan Haight Act waivers, expanded access significantly. Reimbursement parity laws now exist in the majority of U.S. states.
Evidence Base
Randomized controlled trials demonstrate equivalent outcomes for telepsychiatry versus in-person care for ADHD, depression, and anxiety in youth. High levels of patient and family satisfaction are consistently reported across studies. Diagnostic accuracy via telepsychiatry is comparable to in-person assessment for most conditions. Telepsychiatry is effective for medication management, psychotherapy including CBT and supportive therapy, and diagnostic evaluation. Evidence remains limited for very young children under age five and for severe behavioral disturbances.
| Clinical Application | Evidence Level | Effectiveness vs. In-Person | Key Considerations |
|---|---|---|---|
| ADHD follow-up/medication management | RCT evidence | Equivalent | Rating scales easily administered remotely |
| Depression (CBT, IPT-A) | RCT evidence | Equivalent | Passive engagement may be missed on screen |
| Anxiety disorders (CBT) | RCT evidence | Equivalent | Exposure tasks adaptable to home environment |
| Diagnostic evaluation | Observational data | Comparable accuracy | Home observation provides ecological validity |
| Psychotherapy (supportive) | Observational data | Equivalent | Adolescents may prefer telehealth for privacy |
| Children <5 years | Limited evidence | Uncertain | Attention challenges; caregiver involvement essential |
| Severe behavioral disturbance | Limited evidence | Uncertain | Safety concerns; in-person may be preferred |
Clinical Applications
Diagnostic Assessment
Semi-structured interviews and standardized rating scales can be administered remotely. Observation of child behavior in the home environment provides ecologically valid information that may not be available in clinic settings. The mental status examination is feasible with adaptations, such as asking the child to show drawings or toys. Developmental screening may require supplemental in-person evaluation.
Medication Management
Telepsychiatry is well suited for follow-up medication visits, including review of side effects, dose adjustments, and administration of rating scales. Vital signs and weight must be obtained by caregivers or primary care providers. Prescribing controlled substances remotely requires awareness of evolving DEA regulations.
Psychotherapy
CBT, IPT-A, and supportive therapy have been delivered effectively via telehealth. Play therapy adaptations for younger children can use shared screen activities. Group therapy via telehealth is feasible but requires careful attention to confidentiality and group dynamics.
Special Considerations for Youth
Developmental Adaptations
Younger children may have difficulty sustaining attention to a screen, so sessions may need to be shorter. Interactive apps, drawing tools, and screen-sharing can maintain engagement. Involvement of a caregiver in the room is often necessary for children under ten. Adolescents may actually prefer telepsychiatry for its privacy and convenience.
Confidentiality Concerns
Ensuring that the adolescent has a private space for the session is important. Headphones or code words can be used to signal when a caregiver is within earshot. Limits of confidentiality should be addressed at the beginning of each session. Only HIPAA-compliant platforms should be used.
Safety Assessment
Suicide risk assessment via telehealth requires a specific safety protocol. The patient's physical location should be established at the start of each session. A local emergency contact and crisis plan should be documented before beginning treatment. The clinician should know how to contact local emergency services for the patient's location if needed.
Technology and Implementation
HIPAA-compliant platforms include Zoom for Healthcare, Doxy.me, and proprietary EHR-based systems. Minimum requirements include reliable internet, a camera, a microphone, and a private space. The digital divide presents a significant barrier, as families lacking broadband, devices, or digital literacy face difficulty accessing telepsychiatry services. Audio-only visits are a fallback when video is unavailable but provide limited clinical information. Technical issues should be troubleshot proactively, with a backup plan such as a phone call in place.
Collaborative Care Models
Child Psychiatry Access Programs use teleconsultation to support primary care providers in managing psychiatric conditions. School-based telepsychiatry connects students with psychiatrists during the school day. Hub-and-spoke models allow specialists at academic centers to serve rural clinics. Integration with pediatric medical homes enables co-management of complex cases.
Legal, Ethical, and Regulatory Issues
Licensure requirements mandate that clinicians be licensed in the state where the patient is located, though interstate compacts are expanding options. Informed consent should address telepsychiatry-specific risks and limitations. Documentation of patient location and emergency contacts at each session is essential. Evolving DEA regulations for prescribing controlled substances via telehealth must be tracked. Malpractice coverage should explicitly include telehealth services.
Clinical Pearls
Telepsychiatry is not a lesser form of care; evidence supports its efficacy for most child and adolescent psychiatric conditions. Hybrid models combining in-person and telehealth visits offer flexibility and optimize engagement. Always verifying patient location and having a safety plan before beginning a telepsychiatry session is a non-negotiable practice. The digital divide is a health equity issue, and clinicians should proactively address barriers to access for underserved families.
References
- Myers KM, et al. "Child and Adolescent Telepsychiatry: Variations in Utilization, Referral Patterns, and Practice Trends." Journal of Child and Adolescent Psychopharmacology. 2019;29(3):178-189.
- American Academy of Child and Adolescent Psychiatry. "Clinical Update: Telepsychiatry with Children and Adolescents." JAACAP. 2017;56(10):875-893.
- Comer JS, et al. "Remotely Delivering Real-Time Parent Training to the Home: An Initial Randomized Trial of Internet-Delivered Parent-Child Interaction Therapy." Journal of Consulting and Clinical Psychology. 2017;85(9):909-917.